These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
147 related articles for article (PubMed ID: 34411556)
1. Serum hypoxia-inducible factor 1alpha emerges as a prognostic factor for severe traumatic brain injury. Lv QW; Zheng ZQ; Zhang H; Guo M; Shen LJ Clin Chim Acta; 2021 Nov; 522():77-82. PubMed ID: 34411556 [TBL] [Abstract][Full Text] [Related]
2. Potential role of serum hypoxia-inducible factor 1alpha as a biomarker of delayed cerebral ischemia and poor clinical outcome after human aneurysmal subarachnoid hemorrhage: A prospective, longitudinal, multicenter, and observational study. Cai YY; Zhuang YK; Wang WJ; Jiang F; Hu JM; Zhang XL; Zhang LX; Lou XH Front Neurol; 2022; 13():1072351. PubMed ID: 36570456 [TBL] [Abstract][Full Text] [Related]
3. Serum Hypoxia-Inducible Factor 1alpha Levels Correlate with Outcomes After Intracerebral Hemorrhage. Cai Y; Zhuang YK; Wu XY; Dong XQ; Du Q; Yu WH; Wang KY; Hu W; Zheng YK Ther Clin Risk Manag; 2021; 17():717-726. PubMed ID: 34285494 [TBL] [Abstract][Full Text] [Related]
4. A prospective observational study on utility of serum mesencephalic astrocyte-derived neurotrophic factor as a promising prognostic biomarker of severe traumatic brain injury in humans. Wang KW; Zhan CP; Liu YQ; Fu ZZ; Qiu TW; Yu GF Clin Chim Acta; 2023 May; 545():117370. PubMed ID: 37137461 [TBL] [Abstract][Full Text] [Related]
5. Serum biomarkers as predictors of long-term outcome in severe traumatic brain injury: analysis from a randomized placebo-controlled Phase II clinical trial. Raheja A; Sinha S; Samson N; Bhoi S; Subramanian A; Sharma P; Sharma BS J Neurosurg; 2016 Sep; 125(3):631-41. PubMed ID: 26722854 [TBL] [Abstract][Full Text] [Related]
6. [Expression and significance of hypoxia-inducible factor 1α and Bcl-2/adenovirus E1B19kDa-interacting protein 3 in children with traumatic brain injury]. Zhu L; Wang XC; Xu YY; Wang N; Zhu BX; Li ZW Zhongguo Dang Dai Er Ke Za Zhi; 2024 Apr; 26(4):378-384. PubMed ID: 38660902 [TBL] [Abstract][Full Text] [Related]
7. Utility of serum chemokine-like factor 1 as a biomarker of severity and prognosis after severe traumatic brain injury: A prospective observational study. Wu X; Su C; Tian D; Ye Y; Du Q; Chen J; Li H; Liu J Brain Behav; 2024 May; 14(5):e3522. PubMed ID: 38773776 [TBL] [Abstract][Full Text] [Related]
8. Importance of serum IRAK3 as a biochemical marker in relation to severity and neurological outcome of human severe traumatic brain injury: A prospective longitudinal cohort study. Yang K; Yang L; Chen X; Li J; Zheng B; Hu J; Wang H; Yu Q; Song G Clin Chim Acta; 2024 Jan; 553():117754. PubMed ID: 38169195 [TBL] [Abstract][Full Text] [Related]
9. Serum sulfonylurea receptor-1 as a biomarker of clinical severity and prognosis in patients with traumatic brain injury. Ying X; Chen M; Zhang J; Sun CF; Zhou J Clin Chim Acta; 2022 Mar; 528():65-73. PubMed ID: 35092725 [TBL] [Abstract][Full Text] [Related]
10. Temporal change of serum xanthine oxidase levels and its relation to clinical outcome of severe traumatic brain injury: a prospective cohort study. Yan T; Shan H; Wang Z; Zou S; Chen Z; Yu W; Du Q; Dong X Neurosurg Rev; 2023 Dec; 46(1):320. PubMed ID: 38038775 [TBL] [Abstract][Full Text] [Related]
11. Serum calprotectin as a prognostic predictor in severe traumatic brain injury. Yang Y; Shen L; Xu M; Chen L; Lu W; Wang W Clin Chim Acta; 2021 Sep; 520():101-107. PubMed ID: 34102135 [TBL] [Abstract][Full Text] [Related]
12. Elevated concentrations of hypoxia-inducible factor-1α in patients with fracture and concomitant traumatic brain injury. Sang X; Wang Z; Qin T; Li Y Ann Clin Biochem; 2017 Sep; 54(5):584-592. PubMed ID: 27687082 [TBL] [Abstract][Full Text] [Related]
13. A two-center prospective cohort study of serum RIP-3 as a potential biomarker in relation to severity and prognosis after severe traumatic brain injury. Zou S; Xu J; Yang W; Chen Z; Shan H; Liu J; Tian D; Wu X; Du Q; Dong X; Jiang L Neurosurg Rev; 2024 Aug; 47(1):433. PubMed ID: 39141133 [TBL] [Abstract][Full Text] [Related]
14. Serum apelin-13 and risk of death following severe traumatic brain injury. Zhuang Y; Wang W; Chen L; Lu W; Xu M Clin Chim Acta; 2021 May; 516():64-68. PubMed ID: 33508251 [TBL] [Abstract][Full Text] [Related]
15. [Prognostic factors of severe traumatic brain injury and the predictive value of serum translocator protein combined with the reverse shock index multiplied by Glasgow Coma Scale]. Chen X; Zhu L Zhonghua Yi Xue Za Zhi; 2021 Jan; 101(3):218-223. PubMed ID: 33455149 [No Abstract] [Full Text] [Related]
16. Simplifying the use of prognostic information in traumatic brain injury. Part 1: The GCS-Pupils score: an extended index of clinical severity. Brennan PM; Murray GD; Teasdale GM J Neurosurg; 2018 Jun; 128(6):1612-1620. PubMed ID: 29631516 [TBL] [Abstract][Full Text] [Related]
17. The 90-day prognostic value of serum cyclophilin A in traumatic brain injury. Jin HH; Mao TM; Bai ZQ; Chen Y; Ji HL; Jin Y Clin Chim Acta; 2018 Sep; 484():258-264. PubMed ID: 29885319 [TBL] [Abstract][Full Text] [Related]
18. Utility of serum nuclear factor erythroid 2-related factor 2 as a potential prognostic biomarker of severe traumatic brain injury in adults: A prospective cohort study. Yan XJ; Zhan CP; Lv Y; Mao DD; Zhou RC; Xv YM; Yu GF Front Neurol; 2022; 13():1013062. PubMed ID: 36388174 [TBL] [Abstract][Full Text] [Related]
19. Association of Serum Brain-Derived Tau With Clinical Outcome and Longitudinal Change in Patients With Severe Traumatic Brain Injury. Gonzalez-Ortiz F; Dulewicz M; Ashton NJ; Kac PR; Zetterberg H; Andersson E; Yakoub Y; Hanrieder J; Turton M; Harrison P; Nellgård B; Karikari TK; Blennow K JAMA Netw Open; 2023 Jul; 6(7):e2321554. PubMed ID: 37399012 [TBL] [Abstract][Full Text] [Related]
20. Importance of AIM2 as a serum marker for reflecting severity and predicting a poor outcome of human severe traumatic brain injury: A prospective longitudinal cohort study. Chen SH; Hu FL; Wang G; Liang XS; He CJ Clin Chim Acta; 2024 Jun; 559():119691. PubMed ID: 38685373 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]